Tag: IgGenix

Jessica Grossman

IgGenix Secures $40M Funding to Advance Antibody Therapy to Treat Food...

IgGenix, a San Francisco-based biotech company, announced yesterday they had secured $40 million in Series B funding to bring a peanut allergy candidate to...
RNA and Tree Nut Allergy

IgGenix Shows Potential of Platform to Advance Understanding of Tree Nut...

The company is aiming at more targeted therapeutic approaches that have the potential to address key allergens directly.
IgG Antibody

Company Developing Therapy to Prevent “Allergic Cascade” Emerges from Stealth Mode

IgGenix will develop a therapy that focuses on all types of food allergies and related conditions.